Haemonetics Corporation

    Jurisdiction
    United States
    LEI
    549300ZEL6TXZS6F5F95
    ISIN
    US4050241003 (HAE)
    Sectors
    1. Healthcare
    2. Medical - Instruments & Supplies

    Scores

    InsiderPie Expert Score
    51 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    €110.69 156.2% undervalued
    Financial strength (Piotroski F-Value)
    8 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    Haemonetics Corporation, a healthcare company, provides medical products and solutions. Read full profile

    Fundamentals

    Net revenue
    €1.15B
    Gross margin
    56.1%
    EBIT
    €202.32M
    EBIT margin
    17.6%
    Net income
    €139.32M
    Net margin
    12.1%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €1.10B -3.8% €196.03M +40.7%
    €1.18B +6.4% €221.47M +13.0%
    €1.26B +6.8% €246.37M +11.2%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Ray Dalio 22K $1.37M +16K Buy

    Earnings Calls

    Latest earnings call: May 10, 2024 (Q4 2024)

    Add to watchlist

    Notifications